Dermata Therapeutics Inc (DRMA) — Financial Flexibility Index
Latest as of December 2025:
-0.81x
Dermata Therapeutics Inc (DRMA) has a Financial Flexibility Index of -0.81x as of December 2025. Free cash flow of $-1.33 Million (operating CF $-1.33 Million minus capex $3.00) represents -1% of total liabilities ($1.64 Million).
Financial Flexibility Index
-0.81x
Free Cash Flow / Total Liabilities
Free Cash Flow
$-1.33 Million
Operating CF − Capex
Total Liabilities
$1.64 Million
USD
Capital Expenditures
$3.00
USD
Dermata Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Dermata Therapeutics Inc across 7 annual periods. See Dermata Therapeutics Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Dermata Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Dermata Therapeutics Inc. For the full company profile including market capitalisation, see DRMA market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.73x | $-7.76 Billion | $-7.76 Billion | $1.64 Billion | ▲ +16.4% |
| 2024 | -5.66x | $-11.16 Million | $-11.16 Million | $1.97 Million | ▼ -43.3% |
| 2023 | -3.95x | $-6.41 Million | $-6.41 Million | $1.62 Million | ▲ +58.8% |
| 2022 | -9.57x | $-8.83 Million | $-8.83 Million | $922.63K | ▼ -155.1% |
| 2021 | -3.75x | $-5.69 Million | $-5.69 Million | $1.52 Million | ▼ -252.5% |
| 2020 | -1.06x | $-4.03 Million | $-4.03 Million | $3.78 Million | ▲ +38.2% |
| 2019 | -1.72x | $-3.92 Million | $-3.92 Million | $2.28 Million | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities